Corrigendum: Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Comprehensive Bioinformatic Analysis of TONSL Expression in Pan-Cancer.Cancer reports (Hoboken, N.J.) · 2026
   Article
2. Influencing factors and mechanism of hepatocyte regeneration.Journal of translational medicine · 2025
   Review
3. miR-182-5p promotes hepatocyte-stellate cell crosstalk to facilitate liver regeneration.Communications biology · 2022
   Article
4. Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular Cancer.Gene expression · 2020
   Review
5. Hepatic progenitor cell activation is induced by the depletion of the gut microbiome in mice.MicrobiologyOpen · 2019
   Article

Corrections and comments

• Erratum for
  Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration.2017

Authors and funding

14 authors.

Funding

Abstract